Objective This study was designed to compare the association between the body mass index (BMI) and symptoms of gastroesophageal reflux disease (GERD) in allegedly normal subjects undergoing regular medical checkups and subjects diagnosed with non-alcoholic fatty liver disease (NAFLD). Additionally, the correlation between the BMI and GERD symptoms was evaluated in subjects with NAFLD. Methods This study included 50 patients with NAFLD and 228 normal subjects evaluated during regular medical checkups. The height, weight, BMI, frequency scale for the symptoms of GERD (FSSG), and serum concentrations of triglycerides and γ-GTP were compared between the two groups. In the NAFLD group, aspartate aminotransferase (AST) and alanine aminotransferase (ALT) concentrations were measured and insulin resistance was calculated using the quantitative insulin sensitivity check index (QUICKI). Results The total FSSG score moderately correlated with the BMI in the NAFLD group (r=0.342, p= 0.015), but correlated negatively in the control group (r=-0.014, p=0.831). The FSSG score in the NAFLD group also negatively correlated with the AST/ALT ratio (r=-0.319) and insulin resistance calculated using the QUICKI score (r=-0.288). The BMI in the NAFLD group moderately correlated with the acid-reflux related score on the FSSG (r=0.389), and both the AST/ALT ratio (r=-0.344) and QUICKI score (r=-0.330) negatively correlated with the dyspepsia score on the FSSG. Conclusion Obesity evaluated by the BMI was a significant risk factor for the exacerbation of GERD symptoms in subjects with NAFLD.
Introduction
Pathophysiologically, gastroesophageal reflux disease (GERD) is thought to involve the reflux of acidic gastric contents into the esophagus, with these gastric contents remaining long enough to overcome the esophageal epithelium (1) . Obesity has been associated with GERD symptoms in Western subjects (2) (3) (4) . Several hypotheses have been proposed to explain this relationship, including i) increased intra-abdominal and intra-gastric pressure due to abdominal obesity, ii) the formation of an esophageal hiatal hernia, and iii) the intake of large amounts of foods and a high-fat diet, which increase the frequency of transient lower esophageal sphincter relaxation (TLESR). In contrast, the association between obesity and symptoms of GERD in Japanese patients remains unclear (5) (6) (7) (8) (9) , although several studies in Japan have reported that visceral obesity was closely related to endoscopic reflux esophagitis, including Barrett's esophagus in patients with non-alcoholic fatty liver disease (NAFLD) (10) , and metabolic syndrome was a risk factor for endoscopic reflux esophagitis (11) .
Our previous studies demonstrated that visceral fat accumulation, not obesity as indicated using the high body mass index (BMI), was a main risk factor for NAFLD in Japanese individuals and that these subjects could recover from NAFLD by the reduction of fat accumulation (12) (13) (14) (15) . These findings suggested that NAFLD may be related to GERD symptoms. The aim of this study is to compare the association between the BMI and symptoms of GERD in allegedly normal subjects undergoing regular medical checkups and subjects diagnosed with NAFLD. Additionally, this study assessed whether the BMI correlated with GERD symptoms in subjects with NAFLD.
Materials and Methods

Study design and subjects
This study included 278 subjects who visited Eguchi Hospital, Saga, Japan, from April 2009 to March 2010. Study subjects were divided into two groups, consisting of 50 patients treated at the hospital for NAFLD and 228 allegedly healthy subjects undergoing medical checkups. They were evaluated by a retrospective and cross-sectional analysis of charts. Informed consent was acquired for the use of data for research purposes, and written informed consent was obtained from all participants.
Subject height, weight, BMI, frequency scale for the symptoms of GERD (FSSG) (16) , and serum concentrations of triglycerides and gamma-glutamyl transferase (γ-GTP) were evaluated. In the NAFLD group, aspartate aminotransferase (AST) and alanine aminotransferase (ALT) concentrations were measured and insulin resistance was calculated using the quantitative insulin sensitivity check index (QUICKI). The FSSG questionnaire, a GERD-specific questionnaire developed in Japan and used to screen for GERD, was used to assess both acid-reflux related and dyspeptic symptoms of GERD (16) . The FSSG has 12 questions, five regarding acid reflux-related symptoms and seven regarding dyspeptic symptoms (Fig. 1) . Each question was scored to indicate the frequency of symptoms as never =0; occasionally =1; sometimes =2; often =3; and always =4. Subjects with FSSG scores >8 were considered positive for GERD symptoms.
NAFLD was diagnosed according to the following criteria: i) slight diffuse increase in bright homogeneous echoes in the liver parenchyma with normal visualization of the diaphragm and portal and hepatic vein borders and normal hepatorenal echogenicity contrast; ii) diffuse increase in bright echoes in the liver parenchyma with slightly impaired visualization of the peripheral portal and hepatic vein borders; or iii) marked increase in bright echoes at a shallow depth with deep attenuation, impaired visualization of the diaphragm and marked vascular blurring. Subjects were diagnosed with NAFLD if they showed i) an absence of markers of hepatitis B virus infection (hepatitis B surface antigen and anti-hepatitis B core antibody) and hepatitis C virus in- fection (anti-hepatitis C antibody); ii) absence of evidence of autoimmune liver disease; and iii) absence of alcoholic liver disease (<20 g alcohol per day). The QUICKI score, a surrogate index of insulin resistance (17) , was calculated as: QUICKI =1/[log(I0) + log(G0)], where I0 is the fasting plasma insulin concentration (micro units per mL) and G0 is fasting blood glucose level (milligrams per dL).
Each subject group was divided into two FSSG subgroups, those with (FSSG score ! 8) and without (FSSG score <8) symptoms of FSSG, and their BMIs were compared. Additionally, each subject group was divided into three BMI subgroups, those with low (<25 kg/m 2 ), medium (! 25 and <30 kg/m 2 ), and high (! 30 kg/m 2 ) BMIs, and their mean FSSG scores were compared.
Statistical analysis
Patient characteristics were compared using Student's ttest or one way analysis of variance. Correlations between the FSSG scores and BMI and between the AST/ALT ratio and QUICKI in the NAFLD group were evaluated with Pearson's correlation coefficient. Statistical significance was considered to be present at p<0.05. All statistical analyses were performed using the SPSS software program version 19 for Windows (IBM Inc., Chicago, USA).
Results
Subject characteristics
The baseline demographic and clinical characteristics of the 50 patients with NAFLD and the 228 control subjects are shown in Table 1 . Their mean ages were similar (51.4 vs. 51.0 years, respectively). The NAFLD group consisted of 22 men (44.0%) and 28 women (56.0%), whereas the control group consisted of 160 men (70.2%) and 68 women (29.8%). The average BMI was significantly higher in the NAFLD than in the control group (27.2±4.2 vs. 23.1±3.4 kg/m 2 , p<0.05). The total FSSG scores were similar in the two groups, as were their acid-reflux related and dyspeptic symptom scores.
Correlation of the FSSG score with the BMI, AST/ALT ratio and QUICKI score
The total FSSG score was significantly moderately correlated with the BMI in the NAFLD group (r=0.342, p=0.015; Fig. 2 ), but not in the control group (r=-0.014, p=0.831; Fig. 3 ). The total FSSG score in the NAFLD group also showed significant negative correlations with the AST/ALT ratio (r=-0.319) and QUICKI score (r=-0.288; Table 2 ). The BMI in the NAFLD group correlated with the acid-reflux related score on the FSSG, and both the AST/ALT ratio (r= -0.344) and QUICKI score (r=-0.330) negatively correlated with the dyspeptic score on the FSSG.
Subgroup analysis of the FSSG scores and BMI
Subjects in the NAFLD and control groups were subsequently divided into three subgroups according to the BMI (<25 kg/m 2 , ! 25 but <30.0 kg/m 2 , and ! 30.0 kg/m 2 ). The NAFLD subgroup with the highest BMI group had a higher FSSG score than the other two subgroups. However, the FSSG scores did not differ significantly in the three control subgroups (Table 3) .
Discussion
This study indicated that the total FSSG score correlated significantly with the BMI in subjects with NAFLD, but not in the controls. The subgroup analysis showed that the FSSG score was exacerbated in subjects with a BMI greater than 30 kg/m 2 . Abdominal fat accumulation, as determined using a CT scan, was reported to closely correlate with GERD symptoms and Barrett esophagus (18, 19) . Several studies in Japan showed that increased BMI was a risk factor for GERD symptoms and reflux esophagitis, whereas other studies reported that the BMI was not correlated with GERD and GERD symptoms (5-11). We previously showed that the accumulation of visceral fat was an important risk factor for NAFLD (12) . These results support our finding that the BMI correlated with GERD symptoms in patients with NAFLD.
The AST/ALT ratio and QUICKI score showed negative correlations with the total FSSG score in patients with NAFLD. Several studies in Western counties and Japan found that both the AST/ALT ratio and insulin resistance were important risk factors for the severity of NAFLD (20) (21) (22) (23) (24) . Because the severity of NAFLD is apparently due to visceral fat accumulation (12, 24) , the negative correlations observed between the AST/ALT ratio and insulin resistance with the FSSG in the present study suggested that the relationship between the BMI and GERD symptoms may also be dependent on the visceral fat accumulation in subjects with NAFLD.
Several studies suggested the association between symptoms of GERD and insulin resistance (10, 14, 25) . Our previous study suggested that the NAFLD status was positively related to insulin resistance caused by visceral fat accumulation (14) , and the inflammatory changes induced by visceral fat accumulation may induce adipocytokine dysregulation (25) . Adipocytokine dysregulation, especially reduced secretion of adiponectin, could induce lower sphincter tone, leading to the exacerbation GERD symptoms (10, 25) . In the present study, there was a weak association between insulin resistance and GERD symptoms measured by the FSSG, which warrants further examination. This study is associated with several limitations. First, there may have been selection bias in choosing the subjects, since the control group consisted of individuals who visited the hospital for medical checkups, and the NAFLD group included women with higher BMI, consistent with our previous finding that the BMI was higher in subjects with than without NAFLD (15) . Additionally, obesity was evaluated only by measuring the BMI, not by visceral fat estimation using CT. Furthermore, our results may have been altered by other, as yet unidentified, confounding factors. Because of the small sample size, BMI was the only risk factor for GERD symptoms in NAFLD evaluated by a univariate analysis (Table 4) . A cross-sectional study in larger populations with NAFLD will reveal the accurate associations with NAFLD, including sex, the AST/ALT ratio, and insulin resistance, in the future.
In conclusion, this study showed that the severity of GERD symptoms was closely related to the BMI, the AST/ ALT ratio, and insulin resistance in subjects with NAFLD, but not in control subjects. These results suggested that obesity in subjects with NAFLD, including increases in the BMI and visceral fat accumulation, may significantly exacerbate the symptoms of GERD.
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